Flavonoids as potential anti-platelet aggregation agents: from biochemistry to health promoting abilities

Javad Sharifi-Rad1,2, Cristina Quispe3, Shabnum Shaheen4

  • 1Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

Flavonoids from plant extracts show promise in preventing cardiovascular diseases by inhibiting platelet aggregation. Further research is needed to fully understand their mechanisms for treating heart conditions.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Phytochemistry

Background:

  • Cardiovascular diseases are the leading global cause of death, with platelet activation central to arterial disease development.
  • Flavonoids, plant-derived compounds, are recognized for their potential therapeutic benefits in managing heart conditions.
  • Their anti-platelet activity offers a promising avenue for developing novel treatments for thrombotic disorders.

Purpose of the Study:

  • To review the anti-platelet aggregation potential of flavonoids.
  • To emphasize the therapeutic efficacy of flavonoids in human cardiovascular disease treatment.
  • To elucidate the mechanisms underlying flavonoid action in cardiovascular disease prevention and treatment.

Main Methods:

  • Review of preclinical and clinical experimental trials.
  • Analysis of scientific literature on flavonoid anti-platelet activity.
  • Examination of studies investigating flavonoid mechanisms in cardiovascular health.

Main Results:

  • Flavonoid-rich plant extracts demonstrate significant anti-platelet aggregation activity.
  • Evidence from trials supports the protective effects of flavonoids against cardiovascular ailments.
  • Flavonoids exhibit antithrombotic and cardiovascular protective effects.

Conclusions:

  • Flavonoids show therapeutic potential in managing cardiovascular diseases through anti-platelet activity.
  • Further investigation into the molecular mechanisms of flavonoids as anti-platelet agents is warranted.
  • Flavonoids represent a safe, natural approach to combating heart-related mortality.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
803
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.2K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.2K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.3K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.9K